contraindications for glp-1 agonists include Benefits and Risks of Receptor Outlined Glucagon-Like Peptide-1 Receptor Agonists And

It remains an investigational compound available for laboratory research only

It was the first of several DPP-4 inhibitors introduced for treating type 2 diabetes

Many plans are more likely to cover GLP-1 medications when prescribed for FDA approved indications such as Type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea

While these antiinflammatory effects have not been attributed to GLP-1 action in specific organs or cell types, the kidney GLP-1R has been localized primarily to vascular smooth muscle cells within renal arteries and arterioles using either 125 I-labeled exendin-4, a validated antiGLP-1R antibody, or in situ hybridization (71, 72)

This dual action is one reason tirzepatide may support stronger results for some patients compared with GLP-1 treatment alone